I have shared examples of healthcare innovation across vaccines, cardiac care, and artificial intelligence. These posts preserve my enthusiasm for innovation and the claims and examples I described, without treating them as independently verified findings.
I wrote, “Proud to be part of Emcure” and called the claimed vaccine launch “a testament to our commitment to innovation.”
I described Emcure as the “first company to launch mRNA vaccine in India” at “2 to 8 degrees.” The post does not specify the temperature unit or identify the vaccine.
I described Rajat Jain as a “27 yr old Rajat Jain” and a “global pioneer in cardiac care.”
I described Rajat as coming “From a humble village(Parasoli) in UP.”
I said Rajat “has launched 5 groundbreaking products.”
I said the products “have tripled sales.”
I said funds were raised “at 10X valuation.”
I said this happened “within a year of pitching Sunfox Tech at Season 1 of ST.”
I described the event as “A lovely launch event” and said “that I attended” in Dehradun.
I described “a friends death at 21 due to a heart attack” as the motivation behind Rajat’s cardiac-care work.
I said “he did his engineering here,” referring to Dehradun.
I said that rather than setting up in a larger startup metro, “he chose to keep his roots in Dehradun.”
I said Rajat’s goal was “with the goal of creating jobs” and “putting his city on the global map.”
I said, “Emcure has partnered w them” “to create heart attack management centers pan India.”
I said Rajat’s product launch on “World Heart Day, Sep 29” reflected his commitment to heart health.
I said “AI can transform healthcare,” while noting that I had “only skimmed the surface & covered a few areas above.”
I identified “data privacy and related ethics, prohibitive costs and” and “unclear regulations” as challenges to healthcare AI.
I said sepsis is “one of the largest causes of deaths in hospitals” and estimated “11 m deaths/year.”
I said AI can assess “150 patient variables” after emergency-ward check-in to predict possible sepsis risk.
I said, “Staying vigilant has brought down sepsis incidence in hospitals !”
I said GE is “using gen AI for multi modal integration” from “sources like imaging, genomics, pathology.”
I said AI can read ischemic-stroke images to “identify the clot in the brain.”
I wrote, “This speed in diagnosis can save lives.”
I said AI monitoring devices can “send a notification to the healthcare professionals to visit the patient as and when needed,” “saving time.”
I said remote care “limits the number of days patient has to spend in the hospital” and thereby helps with “reducing cost of stay.”
I said AI-trained chatbots “have shown the potential to answer patient questions when doctors are not available.”
I said bringing a drug to market takes “on average more than 10 years” and “costs over 1.9 billion Euros on average.”
I said Merck’s drug-discovery software identifies compounds “from over 60 billion possibilities.”
I described Insilico Medicine as the first company where an AI-discovered drug “has entered phase II clinical trials in US and China.”
I listed clinical-trial monitoring by “identifying adverse events or complications real time” as an AI application.
I included “trial site selection” among AI applications in clinical trials.
I included the ability to “predict enrolment rates” among AI applications in clinical trials.
I wrote, “AI can often spot patterns and correlations that might be missed by humans.”
I described “cost efficiency by automating a lot of the admin paperwork involved in trials.”
I said AI can “predict machine failure and schedule equipment maintenance before breakdown occurs.”
I said AI “ensures timely delivery of raw materials through analysis and prediction of typical delays due to logistics, weather, shortages etc.”
Related: recycling sanitary and medical waste, health conditions and awareness, choosing supplements responsibly